MEDIF (MediPharm Labs) Scaled Net Operating Assets : 0.56 (As of Jun. 2024)

View and export this data going back to 2018. Start your Free Trial

What is MediPharm Labs Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

MediPharm Labs's operating assets for the quarter that ended in Jun. 2024 was $32.00 Mil. MediPharm Labs's operating liabilities for the quarter that ended in Jun. 2024 was $6.87 Mil. MediPharm Labs's Total Assets for the quarter that ended in Mar. 2024 was $45.25 Mil. Therefore, MediPharm Labs's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was 0.56.

MediPharm Labs Scaled Net Operating Assets Historical Data

The historical data trend for MediPharm Labs's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediPharm Labs Scaled Net Operating Assets Chart

MediPharm Labs Annual Data

Trend

Sep17

Sep18

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

Get a 7-Day Free Trial

221.33

0.47

0.42

0.33

0.58

MediPharm Labs Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.78	0.60	0.55	0.54	0.56

Competitive Comparison of MediPharm Labs's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, MediPharm Labs's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MediPharm Labs's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MediPharm Labs's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where MediPharm Labs's Scaled Net Operating Assets falls into.

MediPharm Labs Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

MediPharm Labs's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(34.254	-	6.438)	/	48.211
=	0.58

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	47.657	-	13.403
=	34.254

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	8.148	-	0.051	-	1.659
=	6.438

MediPharm Labs's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jun. 2024 )
=	(Operating Assets (Q: Jun. 2024 )	-	Operating Liabilities (Q: Jun. 2024 ))	/	Total Assets (Q: Mar. 2024 )
=	(31.996	-	6.874)	/	45.246
=	0.56

where

	Operating Assets		(Q: Jun. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	43.664	-	11.668
=	31.996

	Operating Liabilities		(Q: Jun. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	8.924	-	0.034	-	2.016
=	6.874

MediPharm Labs Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of MediPharm Labs's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

MediPharm Labs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MediPharm Labs Corp (OTCPK:MEDIF) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

MLZ:Germany LABS:Canada

Address

151 John Street, Barrie, ON, CAN, L4N 2L1

Website

https://www.medipharmlabs.com

MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis extracts and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets. Geographically company has a presence in Canada, Australia, Germany, and other countries and the majority of revenue derives from Canada.